Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma (mRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient-reported outcomes in daily clinical practice: QUANARIE trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreHealth-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma (mRCC) treated with a tyrosine kinase inhibitor (TKI) using electronic patient-reported outcomes in daily clinical practice: QUANARIE trial
Type de publicationJournal Article
Year of Publication2020
AuteursMouillet G, Falcoz A, Barthelemy P, Geoffrois L, Eymard J-C, Ladoire S, Plaza J, Viel E, Maurina T, Calcagno F, Fritzsch J, Fritzsch J, Djoumakh O, Vernerey D, Thiery-Vuillemin A, Paget-Bailly S
JournalQUALITY OF LIFE RESEARCH
Volume29
PaginationS77-S78
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0962-9343